Moderna asks FDA to authorize first COVID-19 vaccine for very young children

Moderna says its vaccine appears to be about 51 percent effective for children ages 6 months to less than 2 years, and 37 percent effective for those ages 2 to less than 6 years.

The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

(Image credit: Ole Spata/dpa picture alliance via Getty Images)

Read the full post on Health Care : NPR

Rob Stein